Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and erythrosine

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with erythrosine in 1 studies

Compound Research Comparison

Studies
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Trials
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Recent Studies (post-2010)
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Studies
(erythrosine)
Trials
(erythrosine)
Recent Studies (post-2010) (erythrosine)
21984315,4831082,574

Protein Interaction Comparison

ProteinTaxonomydipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination (IC50)erythrosine (IC50)
Genome polyprotein Zika virus1.7
large T antigenBetapolyomavirus macacae13.04

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, R; Huilgol, N; Preetha, A1

Other Studies

1 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and erythrosine

ArticleYear
Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
    The Journal of membrane biology, 2007, Volume: 219, Issue:1-3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane Permeability; Drug Combinations; Fatty Alcohols; Female; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Liposomes; Membrane Fluidity; Membranes, Artificial; Models, Biological; Paclitaxel; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Surface-Active Agents; Uterine Cervical Neoplasms

2007